ELREXFIO 76 mg in 1.9 mL Injection
RxNorm 2644894
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2644894 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ELREXFIO 76 mg in 1.9 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
1.9 mL elranatamab-bcmm 40 mg/ML Injection [Elrexfio]
(Atom ID: 12827746)
SYPrescribable
Synonym (SY):
1.9 mL Elrexfio 40 mg/ML Injection
(Atom ID: 12827747)
PSNPrescribable
Prescribable Name (PSN):
ELREXFIO 76 mg in 1.9 mL Injection
(Atom ID: 12827752)
SYPrescribable
Synonym (SY):
Elrexfio 76 mg per 1.9 mL Injection
(Atom ID: 12827749)
Patient Education
Elranatamab-bcmm
Elranatamab-bcmm is used to treat multiple myeloma (a type of cancer of the bone marrow) that has returned or that did not respond to at least 4 other treatments. Talquetamab-tgvs is in a class of medications called bispecific T-cell engager antibodies. It works by killing cancer cells.
[Learn More]
* Please review the disclaimer below.